BVMFPFRM3
Market cap120mUSD
Dec 23, Last price
6.09BRL
1D
-2.09%
1Q
7.98%
Jan 2017
-23.01%
IPO
-73.49%
Name
Profarma Distribuidora de Produtos Farmaceuticos SA
Chart & Performance
Profile
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 8,661,744 10.82% | 7,816,218 21.88% | 6,413,199 17.00% | |||||||
Cost of revenue | 8,416,126 | 6,782,708 | 5,997,288 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 245,618 | 1,033,510 | 415,911 | |||||||
NOPBT Margin | 2.84% | 13.22% | 6.49% | |||||||
Operating Taxes | 3,735 | (6,070) | (30,367) | |||||||
Tax Rate | 1.52% | |||||||||
NOPAT | 241,883 | 1,039,580 | 446,278 | |||||||
Net income | 70,397 -12.95% | 80,874 3.43% | 78,192 49.41% | |||||||
Dividends | (31,229) | (29,117) | ||||||||
Dividend yield | 4.34% | 4.02% | ||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 298,788 | 221,920 | 206,837 | |||||||
Long-term debt | 1,208,704 | 1,162,799 | 1,128,474 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 67,127 | 54,326 | 62,016 | |||||||
Net debt | 1,268,708 | 1,154,819 | 1,106,548 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 260,899 | 126,322 | 107,576 | |||||||
CAPEX | (14,012) | (10,510) | (13,547) | |||||||
Cash from investing activities | (96,582) | (21,740) | (86,409) | |||||||
Cash from financing activities | (153,829) | (109,844) | (204,442) | |||||||
FCF | 76,008 | 872,269 | 216,094 | |||||||
Balance | ||||||||||
Cash | 193,743 | 183,255 | 188,517 | |||||||
Long term investments | 45,041 | 46,645 | 40,246 | |||||||
Excess cash | ||||||||||
Stockholders' equity | 1,555,392 | 1,683,935 | 1,589,605 | |||||||
Invested Capital | 2,749,850 | 2,499,726 | 2,416,743 | |||||||
ROIC | 9.22% | 42.29% | 19.33% | |||||||
ROCE | 8.80% | 40.67% | 16.94% | |||||||
EV | ||||||||||
Common stock shares outstanding | 122,611 | 122,611 | 122,611 | |||||||
Price | 5.87 59.95% | 3.67 -37.80% | 5.90 -3.28% | |||||||
Market cap | 719,727 59.95% | 449,982 -37.80% | 723,405 -3.28% | |||||||
EV | 2,279,112 | 1,924,381 | 2,219,771 | |||||||
EBITDA | 394,138 | 1,171,731 | 541,797 | |||||||
EV/EBITDA | 5.78 | 1.64 | 4.10 | |||||||
Interest | 168,313 | 149,196 | 76,156 | |||||||
Interest/NOPBT | 68.53% | 14.44% | 18.31% |